List of 200 MCQs from Pharmacology – III for Practice
UNIT–1: Drugs Acting on GIT (MCQs 1–25)
1. Which
drug irreversibly inhibits H⁺/K⁺ ATPase?
A. Ranitidine
B. Famotidine
C. Omeprazole
D. Cimetidine
2.
Misoprostol is a synthetic analogue of:
A. Prostaglandin E1
B. Prostaglandin E2
C. Prostaglandin F2α
D. Thromboxane
3. Which
antacid is systemic?
A. Aluminium hydroxide
B. Magnesium hydroxide
C. Sodium bicarbonate
D. Magaldrate
4.
Sucralfate acts mainly by:
A. Neutralizing acid
B. Inhibiting proton pump
C. Forming protective barrier
D. Inhibiting H2 receptor
Answer: C
5. Drug
of choice for H. pylori eradication includes:
A. Omeprazole + Amoxicillin + Clarithromycin
B. Ranitidine + Metronidazole
C. Sucralfate + Antacid
D. Misoprostol alone
6. Bulk
forming laxative is:
A. Bisacodyl
B. Senna
C. Ispaghula
D. Lactulose
7.
Lactulose acts as:
A. Stimulant laxative
B. Osmotic laxative
C. Bulk laxative
D. Lubricant
8. Drug
used as stool softener:
A. Liquid paraffin
B. Senna
C. Tegaserod
D. Bisacodyl
9. ORS
mainly corrects:
A. Acid secretion
B. Electrolyte imbalance
C. Motility
D. Infection
10. Zinc
in diarrhea reduces:
A. Vomiting
B. Duration and severity
C. Constipation
D. Acid secretion
11.
Loperamide acts by:
A. μ-opioid receptor activation
B. Dopamine antagonism
C. Anticholinergic action
D. 5-HT3 blockade
12.
Ipecac syrup is used as:
A. Antiemetic
B. Emetic
C. Prokinetic
D. Antispasmodic
13.
Apomorphine induces vomiting by acting on:
A. GI tract
B. Chemoreceptor trigger zone
C. Vestibular apparatus
D. Cortex
14.
Ondansetron blocks:
A. D2 receptors
B. H1 receptors
C. 5-HT3 receptors
D. M receptors
15.
Metoclopramide is:
A. H2 blocker
B. Proton pump inhibitor
C. Prokinetic
D. Antacid
16.
Dicyclomine is used as:
A. Laxative
B. Antiemetic
C. Antispasmodic
D. Prokinetic
17.
Hyoscine is classified as:
A. Anticholinergic
B. Antihistamine
C. Dopamine antagonist
D. Opioid
18.
Promethazine belongs to:
A. H2 antihistamine
B. H1 antihistamine
C. Antacid
D. PPI
19.
Domperidone causes fewer CNS effects because it:
A. Is rapidly metabolized
B. Does not cross BBB
C. Has short half-life
D. Is weak D2 blocker
20.
Tegaserod is a:
A. 5-HT4 agonist
B. 5-HT3 antagonist
C. D2 blocker
D. M receptor antagonist
21.
Antacid causing acid rebound:
A. Aluminium hydroxide
B. Magnesium hydroxide
C. Sodium bicarbonate
D. Magaldrate
22.
Bismuth compounds act by:
A. Killing H. pylori
B. Acid suppression
C. Laxative action
D. Anti-motility
23. Probiotics
mainly restore:
A. Acid secretion
B. Normal gut flora
C. Motility
D. Appetite
24.
Appetite stimulant example:
A. Cyproheptadine
B. Metoclopramide
C. Loperamide
D. Ondansetron
25.
Castor oil is classified as:
A. Bulk laxative
B. Osmotic laxative
C. Stimulant purgative
D. Stool softener
UNIT–2: Endocrine Pharmacology (MCQs 26–45)
26. PTU
inhibits:
A. Peripheral conversion of T4 to T3
B. TSH release
C. Thyroid hormone binding
D. Iodide uptake only
27.
Carbimazole is a:
A. Thioamide
B. Iodide
C. Radioactive agent
D. Beta blocker
28.
Radioactive iodine is contraindicated in:
A. Hyperthyroidism
B. Goiter
C. Pregnancy
D. Thyroid cancer
29.
Metformin decreases glucose by:
A. Increasing insulin release
B. Reducing gluconeogenesis
C. Blocking α-glucosidase
D. Activating PPAR-γ
30.
Sulfonylureas act by:
A. Increasing insulin sensitivity
B. Closing K⁺ channels
C. Inhibiting glucose absorption
D. Decreasing insulin degradation
31. Drug
causing hypoglycemia most commonly:
A. Metformin
B. Acarbose
C. Glibenclamide
D. Pioglitazone
32.
Rosiglitazone activates:
A. PPAR-α
B. PPAR-β
C. PPAR-γ
D. AMPK
33.
Sitagliptin inhibits:
A. DPP-4
B. α-glucosidase
C. Insulinase
D. Glucagon
34.
Corticosteroid causing sodium retention:
A. Dexamethasone
B. Prednisolone
C. Fludrocortisone
D. Betamethasone
35. Long
acting glucocorticoid:
A. Hydrocortisone
B. Prednisolone
C. Dexamethasone
D. Cortisone
36.
Oxytocin causes:
A. Uterine relaxation
B. Uterine contraction
C. Cervical dilation only
D. Inhibition of labor
37.
Misoprostol is used for:
A. Tocolysis
B. Induction of labor
C. Suppressing lactation
D. Uterine relaxation
38.
Salbutamol relaxes uterus by:
A. α-agonism
B. β2-agonism
C. Calcium blockade
D. Progesterone effect
39.
Nifedipine relaxes uterus by:
A. β-blockade
B. Calcium channel blockade
C. Prostaglandin inhibition
D. Oxytocin antagonism
40.
Estrogens mainly cause:
A. Endometrial atrophy
B. Endometrial proliferation
C. Ovulation inhibition
D. Uterine relaxation
41. ACTH
stimulates:
A. Thyroid cortex
B. Adrenal cortex
C. Adrenal medulla
D. Pituitary gland
42. DPP-4
inhibitors increase:
A. Insulin resistance
B. Incretin levels
C. Glucagon secretion
D. Lipolysis
43.
Adverse effect of corticosteroids:
A. Hypoglycemia
B. Osteoporosis
C. Weight loss
D. Hypotension
44.
Meglitinides act similar to:
A. Biguanides
B. Sulfonylureas
C. Thiazolidinediones
D. α-glucosidase inhibitors
45. Drug
used for uterine atony:
A. Isoxsuprine
B. Oxytocin
C. Salbutamol
D. Nifedipine
UNIT–3: Antimicrobials (MCQs 46–85)
46.
β-lactam antibiotics inhibit:
A. Protein synthesis
B. DNA synthesis
C. Cell wall synthesis
D. RNA synthesis
47.
Resistance to penicillin occurs due to:
A. Efflux pumps
B. β-lactamase
C. Ribosomal mutation
D. Reduced permeability
48.
Amoxicillin has better oral absorption than:
A. Penicillin G
B. Ampicillin
C. Cloxacillin
D. Piperacillin
49.
Clavulanic acid is a:
A. Antibiotic
B. β-lactamase inhibitor
C. Sulfonamide
D. Antifungal
50.
Cephalosporins are ineffective against:
A. Gram positive bacteria
B. Gram negative bacteria
C. Mycoplasma
D. Streptococcus
51. Drug
of choice for typhoid:
A. Ampicillin
B. Ciprofloxacin
C. Penicillin G
D. Vancomycin
52.
Tetracycline causes discoloration of teeth due to:
A. Chelation with calcium
B. Hepatotoxicity
C. Renal toxicity
D. CNS depression
53.
Chloramphenicol adverse effect:
A. Ototoxicity
B. Gray baby syndrome
C. Nephrotoxicity
D. Tendinitis
54.
Aminoglycosides cause:
A. Hepatotoxicity
B. Ototoxicity
C. Cardiotoxicity
D. Neurotoxicity
55.
Vancomycin adverse effect:
A. Red man syndrome
B. Gray baby syndrome
C. Stevens-Johnson
D. Photosensitivity
56.
Macrolides inhibit:
A. 30S ribosome
B. 50S ribosome
C. DNA gyrase
D. Cell wall
57.
Ciprofloxacin inhibits:
A. Topoisomerase II
B. RNA polymerase
C. Ribosomes
D. Cell wall
58.
Antitubercular drug causing optic neuritis:
A. INH
B. Rifampicin
C. Ethambutol
D. Pyrazinamide
59. INH
adverse effect prevented by:
A. Vitamin B12
B. Pyridoxine
C. Vitamin C
D. Folate
Answer: B
60.
Rifampicin induces:
A. CYP inhibition
B. CYP induction
C. Renal failure
D. Bone marrow suppression
61. Drug
causing red discoloration of urine:
A. INH
B. Rifampicin
C. Ethambutol
D. PAS
62. MDT
for leprosy includes:
A. INH + Rifampicin
B. Dapsone + Clofazimine + Rifampicin
C. Ethambutol + PAS
D. Pyrazinamide + INH
63.
Albendazole acts by:
A. Blocking microtubules
B. Inhibiting glucose uptake
C. Increasing Ca²⁺ permeability
D. Paralysis
64. Drug
for hydatid disease:
A. Niclosamide
B. Albendazole
C. Piperazine
D. Pyrantel
65.
Metronidazole is effective against:
A. Aerobes
B. Anaerobes
C. Fungi
D. Viruses
66.
Diloxanide furoate is:
A. Tissue amoebicide
B. Luminal amoebicide
C. Systemic antifungal
D. Anthelmintic
67.
Amphotericin-B acts by:
A. Inhibiting ergosterol synthesis
B. Binding to ergosterol
C. DNA inhibition
D. Cell wall inhibition
68.
Ketoconazole inhibits:
A. DNA synthesis
B. Protein synthesis
C. Ergosterol synthesis
D. Cell wall synthesis
69.
Griseofulvin is used for:
A. Systemic candidiasis
B. Dermatophytosis
C. Malaria
D. Leprosy
70.
Acyclovir acts by inhibiting:
A. Viral RNA polymerase
B. Viral DNA polymerase
C. Viral protease
D. Viral entry
71.
Zidovudine is:
A. Protease inhibitor
B. NNRTI
C. NRTI
D. Integrase inhibitor
72.
Efavirenz is:
A. NRTI
B. NNRTI
C. Protease inhibitor
D. Fusion inhibitor
73.
Indinavir inhibits:
A. Reverse transcriptase
B. Protease
C. Integrase
D. Fusion
74.
Enfuvirtide inhibits:
A. Viral fusion
B. Protease
C. Polymerase
D. Integrase
75.
Amantadine is used in:
A. HIV
B. Influenza A
C. Herpes
D. Hepatitis
76.
Polymyxin-B causes:
A. Nephrotoxicity
B. Ototoxicity
C. Neurotoxicity
D. All of the above
77.
Clindamycin adverse effect:
A. C. difficile colitis
B. Ototoxicity
C. Photosensitivity
D. Hypoglycemia
78.
Spectinomycin is used in:
A. TB
B. Gonorrhea
C. Leprosy
D. Malaria
79. DOTS
stands for:
A. Direct Oral TB Strategy
B. Directly Observed Treatment Short-course
C. Drug Observed Therapy
D. Disease Oriented TB System
80. PAS
is:
A. First line drug
B. Second line drug
C. Antifungal
D. Antiviral
81.
Streptomycin causes:
A. Hepatotoxicity
B. Ototoxicity
C. Cardiotoxicity
D. Myelosuppression
82.
Fluconazole has good:
A. Oral bioavailability
B. Nephrotoxicity
C. Ototoxicity
D. CNS toxicity
83.
Luliconazole is used topically for:
A. Bacterial infections
B. Dermatophytosis
C. Viral infections
D. Protozoal infections
84.
Praziquantel is drug of choice for:
A. Hookworm
B. Roundworm
C. Schistosomiasis
D. Enterobiasis
85.
Quinolones cause adverse effect on:
A. Tendons
B. Liver
C. Brain
D. Pancreas
UNIT–4: Immunosuppressants & Antineoplastics
(MCQs 86–100)
86.
Cyclosporine inhibits:
A. DNA synthesis
B. Calcineurin
C. mTOR
D. Tubulin
87.
Tacrolimus is similar to:
A. Methotrexate
B. Cyclosporine
C. Azathioprine
D. MMF
88.
Azathioprine inhibits:
A. Purine synthesis
B. Pyrimidine synthesis
C. Protein synthesis
D. RNA synthesis
89.
Methotrexate inhibits:
A. DHFR
B. DNA gyrase
C. RNA polymerase
D. Protease
90.
Sirolimus inhibits:
A. Calcineurin
B. mTOR
C. DNA synthesis
D. Protein synthesis
91.
Muromonab CD3 is:
A. Monoclonal antibody
B. Cytotoxic drug
C. Alkylating agent
D. Antimetabolite
92. BCG
is used as:
A. Immunosuppressant
B. Immunostimulant
C. Antibiotic
D. Antiviral
93.
Cyclophosphamide belongs to:
A. Antimetabolites
B. Alkylating agents
C. Vinca alkaloids
D. Antibiotics
94.
Vincristine inhibits:
A. DNA synthesis
B. RNA synthesis
C. Microtubule formation
D. Protein synthesis
95.
Paclitaxel stabilizes:
A. DNA
B. RNA
C. Microtubules
D. Ribosomes
96.
Doxorubicin adverse effect:
A. Nephrotoxicity
B. Cardiotoxicity
C. Neurotoxicity
D. Ototoxicity
97.
Bleomycin causes:
A. Cardiotoxicity
B. Pulmonary fibrosis
C. Hepatotoxicity
D. Nephrotoxicity
98.
Cisplatin adverse effect:
A. Myelosuppression
B. Nephrotoxicity
C. Hepatotoxicity
D. Hypoglycemia
99.
L-Asparaginase works by:
A. DNA damage
B. Depleting asparagine
C. Alkylation
D. Tubulin inhibition
100.
Etoposide inhibits:
A. DNA gyrase
B. Topoisomerase II
C. DHFR
D. Protease
Answers
1.(C) Omeprazole, 2.(A) Prostaglandin E1, 3.(C)
Sodium bicarbonate, 4.(C) Forming protective barrier, 5.(A) Omeprazole +
Amoxicillin + Clarithromycin, 6.(C) Ispaghula, 7.(B) Osmotic laxative, 8.(A)
Liquid paraffin, 9.(B) Electrolyte imbalance, 10.(B) Duration and severity,
11.(A) μ-opioid receptor activation, 12.(B) Emetic, 13.(B) Chemoreceptor
trigger zone, 14.(C) 5-HT3 receptors, 15.(C) Prokinetic, 16.(C) Antispasmodic,
17.(A) Anticholinergic, 18.(B) H1 antihistamine, 19.(B) Does not cross
blood–brain barrier, 20.(A) 5-HT4 agonist, 21.(C) Sodium bicarbonate, 22.(A)
Killing H. pylori, 23.(B) Restoration of normal gut flora, 24.(A)
Cyproheptadine, 25.(C) Stimulant purgative.
26.(A) Inhibits peripheral conversion of T4 to T3,
27.(A) Thioamide, 28.(C) Pregnancy, 29.(B) Reduction of gluconeogenesis, 30.(B)
Closing potassium channels, 31.(C) Glibenclamide, 32.(C) PPAR-γ activation,
33.(A) DPP-4 inhibition, 34.(C) Fludrocortisone, 35.(C) Dexamethasone, 36.(B)
Uterine contraction, 37.(B) Induction of labor, 38.(B) β2-agonism, 39.(B)
Calcium channel blockade, 40.(B) Endometrial proliferation, 41.(B) Adrenal
cortex stimulation, 42.(B) Increased incretin levels, 43.(B) Osteoporosis,
44.(B) Sulfonylureas, 45.(B) Oxytocin.
46.(C) Cell wall synthesis inhibition, 47.(B) β-lactamase
production, 48.(B) Ampicillin, 49.(B) β-lactamase inhibitor, 50.(C) Mycoplasma,
51.(B) Ciprofloxacin, 52.(A) Chelation with calcium, 53.(B) Gray baby syndrome,
54.(B) Ototoxicity, 55.(A) Red man syndrome, 56.(B) 50S ribosomal inhibition,
57.(A) Topoisomerase II inhibition, 58.(C) Ethambutol, 59.(B) Pyridoxine,
60.(B) Cytochrome P450 enzyme induction, 61.(B) Rifampicin, 62.(B) Dapsone +
Clofazimine + Rifampicin, 63.(B) Inhibition of glucose uptake, 64.(B)
Albendazole, 65.(B) Anaerobic bacteria, 66.(B) Luminal amoebicide, 67.(B)
Binding to ergosterol, 68.(C) Ergosterol synthesis inhibition, 69.(B)
Dermatophytosis, 70.(B) Viral DNA polymerase inhibition, 71.(C) NRTI, 72.(B)
NNRTI, 73.(B) Protease inhibition, 74.(A) Viral fusion inhibition, 75.(B) Influenza
A, 76.(D) Nephrotoxicity, ototoxicity and neurotoxicity, 77.(A) Clostridium
difficile colitis, 78.(B) Gonorrhea, 79.(B) Directly Observed Treatment
Short-course, 80.(B) Second-line antitubercular drug, 81.(B) Ototoxicity,
82.(A) Good oral bioavailability, 83.(B) Dermatophytosis, 84.(C)
Schistosomiasis, 85.(A) Tendon damage.
86.(B) Calcineurin inhibition, 87.(B) Cyclosporine,
88.(A) Purine synthesis inhibition, 89.(A) Dihydrofolate reductase inhibition,
90.(B) mTOR inhibition, 91.(A) Monoclonal antibody, 92.(B) Immunostimulant,
93.(B) Alkylating agent, 94.(C) Inhibition of microtubule formation, 95.(C)
Stabilization of microtubules, 96.(B) Cardiotoxicity, 97.(B) Pulmonary
fibrosis, 98.(B) Nephrotoxicity, 99.(B) Depletion of asparagine, 100.(B)
Topoisomerase II inhibition.
+
List of 100 MCQs from Pharmacology – III for Practice with Answers
END OF THE DOCUMENT
No comments:
Post a Comment